patent/CN-105175479-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105175479-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate	2010-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8efbc1c278630214c1ac6c772cc2fa97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ae4b354212ba83006f3610966dbc92c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0e66aa3c64857d194fccf81f68ecdf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4230151735fa3294125ab6646e7dcfa
publicationDate	2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-105175479-A
titleOfInvention	Isoxazolidine Derivatives
abstract	The present invention relates to novel anti-inflammatory and anti-allergic compounds of the glucocorticosteroid series, processes for the preparation of said compounds, pharmaceutical compositions containing them, combinations and therapeutic uses thereof. More particularly, the present invention relates to glucocorticosteroids which are isoxazolidine derivatives.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109206471-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112142820-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109206471-A
priorityDate	2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101282987-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102482318-B
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466374052 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410441429 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466384487 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21507141 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467398711 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467366305

Total number of triples: 40.